Will Medtronic plc report Above 7% cardiovascular organic revenue growth in Q1 2027?
KalshiSettled Yes
Yes
Settled Sep 1, 2026
Opening and final price only · ring: settled Yes (100%), not a trade
What moved it
The largest moves on the record and what Langbot heard or read just before each one. Timing, not cause.
Langbot has the opening and final price for this market, not the path between them.
The rules
Kalshi's rules, as the venue wrote them.
If Medtronic plc reports Above 7% cardiovascular organic revenue growth in Q1 2027, then the market resolves to Yes.
Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company.
All trademarks, logos, and brand names are the property of their respective owners.
- Ticker
- KXMDT-26SEPCARDGROW-7
- Closes
- Sep 1, 2026
- Category
- Financials
Test an idea on this market
Open it in the Langbot app to see the market brief, set alerts on its phrases and test a strategy on the events Langbot has recorded.
Test an idea on this market